Valeant Pharma (VRX) Ramps to Session Highs Following Analyst Upgrade

August 17, 2016 12:00 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Valeant Pharma (NYSE: VRX) shares are reaching new session highs midday Wednesday. The stock is up well over 13 percent with high volume.

Notably, Morgan Stanley upgraded the stock earlier. For more color on the call, click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Short Sales, Trader Talk

Related Entities

Morgan Stanley

Add Your Comment